Jove
Visualize
お問い合わせ

関連する概念動画

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

4.5K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
4.5K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

1.3K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.3K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

617
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
617
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

1.1K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.1K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.4K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.4K
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

683
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
683

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Remote, bivariate prior elicitation for a Bayesian non-inferiority randomized controlled trial.

Trials·2026
Same author

AI for predicting exacerbations in KIDs with asthma (AIRE-KIDS).

NPJ digital medicine·2026
Same author

Achievable Benchmarks of Care in Pediatric Emergency Departments.

JAMA network open·2026
Same author

Azithromycin for Preschoolers with Wheezing in the Emergency Department.

The New England journal of medicine·2026
Same author

Persistent Vomiting Among Children With Acute Gastroenteritis: A Secondary Analysis of a Randomized Clinical Trial.

JAMA network open·2026
Same author

Performance of Open-Source LLMs in Identifying Pediatric Pneumonia From Free-Text Chest Radiograph Reports.

Pediatric emergency care·2026
Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026
Same journal

Documenting hospice care.

Lancet (London, England)·2026
Same journal

After the wood chipper.

Lancet (London, England)·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
関連記事をすべて見る
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

Updated: Mar 16, 2026

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

17.5K

ウイルス性肺炎

Todd A Florin1, Amy C Plint2, Joseph J Zorc3

  • 1Division of Pediatric Emergency Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Lancet (London, England)
|August 24, 2016
PubMed
まとめ
この要約は機械生成です。

乳児のウイルス性肺炎は臨床診断が必要で,酸素と水分を中心にサポートケアを行う必要があります. ブロンコディラータとコルチコステロイドは,最初のエピソードに対して証明された利点を提供していません.

さらに関連する動画

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

8.4K
Optimal Lentivirus Production and Cell Culture Conditions Necessary to Successfully Transduce Primary Human Bronchial Epithelial Cells
09:12

Optimal Lentivirus Production and Cell Culture Conditions Necessary to Successfully Transduce Primary Human Bronchial Epithelial Cells

Published on: July 22, 2016

20.5K

関連する実験動画

Last Updated: Mar 16, 2026

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

17.5K
An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

8.4K
Optimal Lentivirus Production and Cell Culture Conditions Necessary to Successfully Transduce Primary Human Bronchial Epithelial Cells
09:12

Optimal Lentivirus Production and Cell Culture Conditions Necessary to Successfully Transduce Primary Human Bronchial Epithelial Cells

Published on: July 22, 2016

20.5K

科学分野:

  • 小児科
  • 感染症
  • 呼吸器医学

背景:

  • ウイルス性支氣管炎は,乳児および幼い子供の呼吸器疾患である.
  • 体系的なレビューと臨床実践ガイドラインにまとめられた重要な研究が存在します.
  • 懸念事項には,この状態に関連した罹病率と医療費が含まれます.

研究 の 目的:

  • ウイルス性支氣管炎の診断と管理のための現在の証拠とガイドラインをレビューする.
  • 様々な治療法の有効性を評価する.
  • 小児の呼吸器感染症の臨床診察を参考にする.

主な方法:

  • 既存の研究と臨床実践のガイドラインを体系的に検討する.
  • 診断検査,サポートケア,薬理学的介入に関する証拠の分析
  • 重篤な症例における高度呼吸器支援に関するデータの評価

主要な成果:

  • 典型的なウイルス性ブロンキオ炎の場合,臨床診断が推奨されます.
  • 酸素と水分を中心にサポート管理を行うのが標準です.
  • 支柱管拡張剤とコルチコステロイドは,第1回支柱管炎の治療に効果を示さない.
  • 塩分濃度の高さの証拠は まだ進化しています
  • 高流量鼻カヌーラとCPAPは重篤な症例に役立ちますが,データは限られています.

結論:

  • ウイルス性支氣管炎の診断は臨床的評価に依存し,診断検査を最小限にします.
  • サポートケアは経営の礎です
  • 現状の証拠は, bronchodilatorsやコルチコステロイドの日常的な使用を支持していません.
  • ハイパートニック塩溶液や 呼吸支援などの治療にはさらなる研究が必要です